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ABSTRACT
The human spermatogonial compartment is essential for daily
production of millions of sperm. Despite this crucial role, the molecular
signature, kinetic behavior and regulation of human spermatogonia are
poorly understood. Using human testis biopsies with normal
spermatogenesis and by studying marker protein expression, we have
identified for the first time different subpopulations of spermatogonia.
MAGE-A4marks all spermatogonia, KITmarks all B spermatogonia and
UCLH1 all Apale-dark (Ap-d) spermatogonia. We suggest that at the
start of the spermatogenic lineage there are Ap-d spermatogonia that
are GFRA1High, likely including the spermatogonial stem cells. Next,
UTF1 becomes expressed, cells become quiescent and GFRA1
expression decreases. Finally, GFRA1 expression is lost and
subsequently cells differentiate into B spermatogonia, losing UTF1
and acquiring KIT expression. Strikingly, most human Ap-d
spermatogonia are out of the cell cycle and even differentiating type B
spermatogonial proliferation is restricted. A novel scheme for human
spermatogonial development is proposed that will facilitate further
research in this field, the understanding of cases of infertility and the
development of methods to increase sperm output.
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INTRODUCTION
Although extensive studies have yielded considerable information
about spermatogenesis in non-primate mammals, our understanding
of this process in primates and especially in humans is still scant. In
both primates and non-primates, at the start of spermatogenesis there
are so-called undifferentiated spermatogonia. In non-primates, this
compartment consists of single spermatogonia (As), and pairs (Apr)
and chains (Aal) of spermatogonia. The spermatogonial stem cells
(SSCs) are among the As spermatogonia (Aloisio et al., 2014; Chan
et al., 2014; de Rooij and Russell, 2000; Helsel et al., 2017; Komai
et al., 2014; Oatley et al., 2011). In primates, this compartment
consists of Apale (Ap) and Adark (Ad) spermatogonia. The Ap
spermatogonial nuclei stain lightly and evenly with Hematoxylin,
and the Ad nuclei stain darkly and, in humans, show a non-staining
rarefaction zone in the middle of the nucleus. Intriguingly, the Ad
spermatogonia do not or rarely incorporate S phase markers such as
3H-thymidine or BrdU (Clermont, 1966a,b, 1969; Clermont and
Antar, 1973; Simorangkir et al., 2009), and are therefore considered
to be quiescent. Several opinions exist as to the function of the Ap
and Ad spermatogonia: (1) the Ad spermatogonia are the true stem
cells that slowly produce Ap spermatogonia that would not have
enough self-renewal capacity to maintain their numbers (Clermont,
1966a,b; Ehmcke et al., 2006); (2) the Ap spermatogonia are the
SSCs as they produce differentiating spermatogonia, maintain
themselves and produce quiescent Ad spermatogonia that, if Ap
spermatogonia are lost, can convert into Ap spermatogonia again
(Clermont, 1966a,b; Ehmcke and Schlatt, 2006; Hermann et al.,
2010; van Alphen et al., 1988); (3) Ap and Ad are similar cells but in
different phases of the cell cycle (Fouquet and Dadoune, 1986;
Hermann et al., 2009, 2010).
In most monkey species and non-primate mammals, whole
stretches of seminiferous tubules are in the same stage of the cycle of
the seminiferous epithelium and subsequent stages follow
sequentially along the length of the tubule. In contrast, in the
human the epithelial stages occupy only small areas of the tubule
basal lamina, and neighboring areas are in randomly different
epithelial stages (Johnson, 1994). The reason for this difference is
supposed to be related to spermatogonial behavior.
Using testis material from human organ donors, we studied the
proliferative activity and differentiation of human spermatogonial cell
types to understand the seemingly large differences between human
and non-primate spermatogenesis. The expression patterns of GFRA1,
UCH-L1, KIT and UTF1 allowed us to distinguish spermatogonial
subtypes and the expression of KI67 gave us information about the
proliferative activity of these cell types. We established the clonal sizes
of Ap and B spermatogonia, and the number of generations of B
spermatogonia. A novel concept of human spermatogonial
proliferation is proposed. This new view on human spermatogonial
behavior will greatly facilitate attempts to better understand abnormal
spermatogenesis present in male infertility.
RESULTS
Characterization of human spermatogonia
In rodents, great progress was made by characterizing
spermatogonial cell types in whole mounts of seminiferous
tubules stained with Hematoxylin. Application of this technique
to human seminiferous tubules demonstrated clearly recognizable
Ap and Ad spermatogonia (Clermont, 1966b). However, often these
cells had an intermediate morphology. For example, some cells had
nuclei that stained lightly with Hematoxylin as Ap, but had a nuclear
rarefaction zone characteristic of Ad spermatogonial nuclei
(Fig. 1A). In particular, in whole mounts, in which the whole
nucleus is visible, it is often too difficult to distinguish Ap and Ad
spermatogonia, suggesting a gradual transition from Ap to Ad
spermatogonia and/or vice versa. In addition the morphologicalReceived 6 February 2017; Accepted 15 August 2017
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analysis of fluorescent-stained nuclei does not allow a clear
distinction between Ap and Ad spermatogonia (Fig. 1B). Because
of this and because, to date, the specific function of Ap and Ad
spermatogonia has remained unclear, we decided to no longer
distinguish between Ap and Ad spermatogonia and to use the term
Ap-d to indicate the total population of Ap and Ad spermatogonia.
A further complication in spermatogonial recognition in humans is
that specific fixation methods are required to distinguish B from
Ap-d spermatogonia (Clermont, 1966b; Rowley and Heller, 1971).
Spermatogonial density on the basal lamina of human
seminiferous tubules is high. Solid packs of KIT− Ap-d
spermatogonia, of KIT+ B spermatogonia or mixtures of these cell
types can be seen (Fig. S1). Indeed, human spermatogonial density
is so high that the nuclei of the Sertoli cells moved to the second
layer of cells above the basal lamina (Fig. S1). It proved to be
impossible to discern individual clones of spermatogonia,
connected by intercellular bridges, as in rodents (de Rooij, 1973;
Huckins, 1971; Lok et al., 1982).
We decided to use marker proteins to distinguish human
spermatogonial cell types. To identify Ap-d and B spermatogonia
we used MAGE-A4, UCH-L1 and KIT. MAGE-A4 is expressed in
all types of spermatogonia (Aubry et al., 2001), UCH-L1 is expressed
in Ad-p spermatogonia (Tokunaga et al., 1999a,b), while KIT is
specifically expressed in differentiating type spermatogonia
(Schrans-Stassen et al., 1999). In prepubertal monkey testes that
contain only Ap-d spermatogonia, no KIT staining was found
(Hermann et al., 2009). Whole mounts of seminiferous tubules were
immunofluorescently stained for MAGE-A4 and UCH-L1 (Fig. 1C)
or MAGE-A4 and KIT (Fig. 1E). UCH-L1 and KIT expression did
not overlap, with only few spermatogonia weakly expressing UCHL-
1 also weakly stained for KIT (Fig. 1G). Using these markers, UCH-
L1+ /KIT−/MAGE-A4+ cells represent the Ap-d spermatogonia
and the UCH-L1−/KIT+/MAGE-A4+ cells represent the B
spermatogonia. We found that 37±4% of the MAGE-A4+ cells
were KIT+ and therefore B spermatogonia and 63±6% of theMAGE-
A4 were UCH-L1+ and therefore Ap-d spermatogonia (Fig. 1D,F).
MAGE-A4 expression was weaker in B than in Ap-d spermatogonia,
and was absent in preleptotene spermatocytes (Fig. S2).
Expression of GFRA1 and UTF1 in Ap-d spermatogonia
We next analyzed expression of selected markers within the
population of Ap-d by double or triple immunostaining for MAGE-
A4 and/or UCH-L1. GFRA1 is a co-receptor for GDNF: a growth
factor produced by Sertoli cells and peritubular cells (Singh et al.,
2017; Spinnler et al., 2010) that regulates self-renewal and
differentiation of murine SSCs, and stimulates the proliferative
activity of undifferentiated spermatogonia. GFRA1 is a consensus
marker for early undifferentiated spermatogonia, including SSCs
(Meng et al., 2000), and is heterogeneously expressed in human Ad
and Ap spermatogonia (Grisanti et al., 2009). KIT and GFRA1
double staining revealed no double-positive cells (data not shown),
indicating that B spermatogonia do not express GFRA1. By double
immunostaining for MAGE-A4 and GFRA1, we found that GFRA1
is expressed in 54±8% of all spermatogonia (Fig. 2A,B) and in 87±
Fig. 1. Characterization of human spermatogonia.
(A) View of the cells on the basal lamina of a human
seminiferous tubule stained lightly with Hematoxylin.
Note the high density of spermatogonia and the
variability of their morphology. Cells can be seen that
are clearly Ap (asterisks) and Ad (arrowheads)
spermatogonia. However, there are many nuclei with
an intermediate morphology. Indeed, there may be a
transition from Ap to Ad (follow the numbers 1 to 5).
Intact seminiferous tubules were formalin fixed and
lightly stained with hematoxylin. Scale bar: 8 µm.
(B) Cells on the basal lamina of an intact human
seminiferous tubule stained with a fluorescent dye for
nuclear DNA. Note that no distinction can be made
between Ap and Ad spermatogonia. Scale bar: 8 µm
(C,E,G) Representative images of intact seminiferous
tubules stained for UCH-L1 and MAGE-A4 (C),
MAGE-A4 and KIT (E), and UCH-L1 and KIT (G).
Scale bars: 20 µm. (D,F) Quantification of the relative
proportion of Ap-d (UCH-L1+/MAGE-A4+) and B (KIT+/
MAGE-A4+) spermatogonia. (D) 1963 UCH-L1+/
MAGE-A4+ cells were scored in three samples.
(F) 3315 KIT+/MAGEA-A4+ cells were scored in four
samples. *P<0.05, ***P<0.001 (Student’s t-test).
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2% of the Ap-d spermatogonia by double immunostaining for
UCH-L1 and GFRA1 (Fig. S3A).
UTF1 is a stably chromatin-associated, transcriptional repressor
protein that is expressed in Ap-d spermatogonia (von Kopylow
et al., 2010, 2012). It is involved in the regulation of differentiation
of ES and EC cells (Lin et al., 2012; van den Boom et al., 2007).
UTF1 was expressed in 43±3% (Fig. 2C,D) of total spermatogonia
and in 56±4% of the Ap-d spermatogonia (Fig. S3B). A few B
spermatogonia weakly expressing KIT also weakly stained for
UTF1 (Fig. 2E). We conclude that UTF1 is expressed in many Ap-d
spermatogonia and in only a few B spermatogonia.
Since both GFRA1 and UTF1 are expressed in many Ap-d
spermatogonia, this indicates that they are co-expressed in someAp-d
spermatogonia. In wholemounts stained forMAGE-A4, GFRA1 and
UTF1, we found that 38±5% of the spermatogonia were GFRA1+,
17±5% were UTF1+ and 25±8% of the cells were double positive for
GFRA1 and UTF1 (Fig. 2F,G). Similar results were obtained in
whole mounts stained for UCH-L1, GFRA1 and UTF1 (Fig. S3C).
Interestingly, we observed a clear difference in expression levels of
GFRA1 in UTF1-positive and -negative spermatogonia (Fig. 2F).
Quantifying the fluorescence intensity of GFRA1 in the two subsets
revealed that the level of GFRA1 in the GFRA+/UTF1− Ap-d was
twice as high as in GFRA1+/UTF1+ Ap-d spermatogonia (Fig. 2H).
Proliferative activity of human Ap-d spermatogonia
To learn about the proliferative activity of the Ap-d spermatogonia,
we stained tubule whole mounts for KI67, a marker of cells in all
phases of the cell cycle except G0 (Birner et al., 2001; Gerdes et al.,
1984; Scholzen and Gerdes, 2000). In this experiment, MAGEA4+/
KI67+/KIT− spermatogonia represent Ap-d spermatogonia in active
cell cycle. KI67+ Ap-d spermatogonia were single, or in pairs or
small groups of up to 6 cells (Fig. 3A). Only 5±2% of the Ap-d
spermatogonia appeared positive for KI67 (Fig. 3B), indicating that
95±2% of the Ap-d spermatogonia are not in active cell cycle. Co-
staining with MAGE-A4, GFRA1 and KI67 showed a comparable
percentage of KI67+ Ap-d (6±2%), strongly suggesting that GFRA1
expression captures all the Ap-d spermatogonia that are in active cell
cycle (Fig. S4).
Interestingly, UTF1+ Ap-d spermatogonia never stained for KI67 or
for EdU (data not shown), indicating that UTF1+ cells were quiescent.
Therefore, all KI67+Ap-dwereGFRA1High/UTF1−.When only 6%of
the Ap-d spermatogonia are KI67+, it can be calculated that about 15%
of GFRA1+/UTF1− (6% of 38%) are in active cell cycle.
These results suggest that early Ap-d spermatogonia are
GFRA1 High/UTF1−, and that these cells slowly proliferate. When
UTF1 becomes expressed, these cells become quiescent and
GFRA1 levels decrease.
Ap-d spermatogonia are mostly single cells and proliferate
throughout the epithelial cycle
To study the topographical arrangement of Ap-d spermatogonia, we
used the mitotic marker phosphohistone-H3 (PHH3) in whole-
mounted seminiferous tubules. Mitosis takes only 2 h and as clones
of Ap-d spermatogonia are not synchronized with each other, at any
given moment few Ap-d spermatogonia will be in mitosis, allowing
one to observe clonal sizes despite the high spermatogonial density.
Mitotic Ap-d spermatogonia (MAGE-A4+/KIT−/PHH3+) were rare
and were mostly single cells (74±4%) and some pairs (26±4%). The
Fig. 2. Expression of GFRA1 and UTF1 in human spermatogonia. (A,B) Quantification of the relative proportion of GFRA1+ and GFRA1− in human
spermatogonia. (A) Representative images of intact seminiferous tubules co-stained for MAGE-A4 and GFRA1. (B) A total of 5850 GFRA1+/MAGE-A4 and
5350 GFRA1−/MAGE-A4 cells were scored in five samples. (C,D) Quantification of the relative proportion of UTF1+ and UTF1− in human spermatogonia.
(C) Representative images of intact seminiferous tubules co-stained forMAGE-A4 and UTF1. (D) A total of 3316 UTF1+/MAGE-A4 and 4463UTF1−/MAGE-A4 cells
were scored in three samples. *P<0.05 (Student’s t-test). (E) Representative images of intact seminiferous tubules co-stained for KIT and UTF1. Double arrows
indicate KIT+/UTF1+ spermatogonia. KIT staining is weak in double-positive cells. (F,G) Quantification of the co-expression of GFRA1 and UTF1 among human
spermatogonia. (F) Representative images of intact seminiferous tubules co-stained for MAGE-A4, GFRA1 and UTF1. Arrowhead indicates GFRA1+/UTF1−;
arrow indicates GFRA1+/UTF1+. GFRA1 expression levels are higher in the GFRA1+/UTF1− Ap-d spermatogonia. (G) A total of 1467 GFRA1+, 684 UTF1+ and 974
GFRA+/UTF1+ cells were scored in three samples. (H) Data are from n=3 samples for a total of 240 cells analyzed. In each sample, 40 GFRA1/UTF1− Ap-d and 40
GFRA1/UTF1+ Ap-d were analyzed. ***P<0.001 (Student’s t-test). Scale bars: 20 µm.
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pairs may either be two single Ap-d spermatogonia that
coincidentally entered mitosis simultaneously or a true pair of Ap-
d spermatogonia connected by an intercellular bridge (Fig. 3C,D).
No chains of mitotic Ap-d spermatogonia were observed. This
indicates that, in humans, most, if not all, Ap-d spermatogonia are
single cells. Apparently, human undifferentiated spermatogonia do
not, or rarely, form pairs and chains of cells as frequently occurs in
rodents. Therefore, it will be mostly single Ap-d spermatogonia that
differentiate into B spermatogonia. Single KIT+/PHH3+ cells, that
should represent the division of the first generation of B
spermatogonia, were observed. In response to the differentiation
into B spermatogonia of some Ap-d spermatogonia, a comparable
number of Ap-d spermatogonia should divide to replenish the cells
lost to differentiation. Indeed, the number of dividing single KIT−/
PHH3+ Ap-d spermatogonia was comparable with that of single
KIT+/PHH3+ B spermatogonia (43±7% versus 57±7%, Fig. 3E).
We then asked whether divisions of Ap-d occur during particular
stages of the epithelial cycle. In testis sections, mitotic spermatogonia
were made clearly visible by immunofluorescent staining for PHH3
and for KIT, while epithelial stages were made visible by acrosin co-
staining (Muciaccia et al., 2013). Again, mitotic figures of the KIT−
Ap-d spermatogonia were rare (Fig. 3F). In samples from six donors,
64 KIT−mitoses of Ap-d spermatogonia were found that were spread
throughout the epithelial stages, although numbers tended to be
highest during stage IX (Fig. 3G). Hence, Ap-d spermatogonia
proliferate throughout the epithelial cycle.
Three generations of human differentiating type B
spermatogonia
In mammals, successive generations of differentiating spermatogonia
divide synchronously during specific stages of the epithelial cycle.
Generally, the number of peaks of mitotic spermatogonia during the
Fig. 3. Kinetics of human Ap-d spermatogonia.
(A,B) Proliferation index of Ap-d. (A) Representative
images of intact seminiferous tubules co-stained for
KI67 to detect proliferating cells, MAGE-A4 and KIT.
Dashed circles show a single (left), a pair (center)
and a group (right) of KI67+ Ap-d (MAGE-A4+/KIT−).
(B) Quantification of proliferation index in three
samples. A total of 102 KI67+ Ap-d were scored out
of 2235 Ap-d. ***P<0.001 (Student’s t-test).
(C,D) Quantification of the relative proportion of
single and paired Ap-d (KIT−/MAGE-A4+/PHH3+).
(C) Representative images of intact seminiferous
tubules co-stained for PHH3 to detect mitotic
spermatogonia, for MAGE-A4 and for KIT. Single
arrows indicate a single Ap-d; double arrows
indicate a paired Ap-d. Dashed lines indicate the
outline of the seminiferous tubules. (D) Relative
proportion of single and paired Ap-d and 12 KIT−
pairs were scored in five samples. ***P<0.001
(Student’s t-test). (E) Quantification of the relative
proportion of single Ap-d (KIT−/MAGE-A4+/PHH3+)
and single B (KIT+/MAGE-A4+/PHH3+)
spermatogonia. A total of 37 KIT− and 55 KIT+
single cells were scored in five samples.
(F,G) Distribution of mitotic Ap-d during the cycle of
the seminiferous epithelium. (F) Representative
images of formalin-fixed testis section stained for
PHH3 to detect mitotic cells, KIT a marker of B
spermatogonia and acrosin to visualize the
epithelial stage. Nuclei are stained with TO-PRO-3.
Single arrow indicates mitotic Ap-d at stage VI.
(G) Histogram showing percentage of mitotic Ap-d
(PHH3+/KIT−) per stage. A total of 64 PHH3+/KIT−
spermatogonia were counted in six samples.
a*P<0.05 stage IX versus stage V, VI and VIII;
a**P<0.005 stage IX versus III and XI; a***P<0.001
stage IX versus I, II, IV, X and XII; b*P<0.05 stage
VIII versus X and XII; c*P<0.05 stage V versus X and
XII. Scale bars: 10 µm.
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epithelial cycle equals the number of generations of differentiating
spermatogonia. To reassess this number in the human, we used the
12-stage classification of the epithelial cycle (Muciaccia et al., 2013)
and triple immunofluorescent staining of testis sections for acrosin to
distinguish epithelial stages, for PHH3 to detect mitoses and for KIT
to detect B spermatogonia. In total, 260 KIT+ mitoses were observed
in sections of six donors (Fig. 4A). Clear peaks of mitotic activity of
KIT+ mitotic spermatogonia were found in epithelial stages IX, II/III
and V/VI, indicating that in the human there are three generations
of differentiating spermatogonia (Fig. 4B). As in primates,
differentiating spermatogonia are named B spermatogonia, these
should be called B1, B2 and B3 spermatogonia, respectively. Our
observations suggest that most, if not all, B spermatogonia are formed
by differentiation of single Ap-d spermatogonia. When the B1
spermatogonia are singles, the B2 spermatogoniawill be pairs and the
B3 spermatogoniawill be chains of four that will divide into chains of
eight preleptotene spermatocytes.
During spermatogenesis, germ cells in the differentiation pathway
form clones of cells that after division remain connected by
intercellular bridges and move through the cell cycle
synchronously. We analyzed the topographical arrangement of
clones of mitotic B spermatogonia in tubule whole mounts
fluorescently stained for KIT and PHH3 (Fig. 4C). Mitotic clones
of B1, B2 and B3 spermatogonia were always found in groups
ranging from three to 32 cells in which sometimes singles, pairs and
larger clones could be distinguished (Fig. 4D). This indicates that
relatively frequently, multiple clones of B spermatogonia
synchronously traverse the cell cycle, causing them to enter mitosis
simultaneously.
The regulation of human differentiating spermatogonial
numbers
The number of three generations of B spermatogonia is higher than
the one generation previously suggested by Clermont (Clermont,
1966b) but is still surprisingly low compared with the five to six
generations of differentiating type spermatogonia observed in other
mammals. We hypothesized that the number of human B
spermatogonial divisions is downregulated, possibly because of
the exceptionally high spermatogonial density. We therefore asked
whether all B spermatogonia are in active cell cycle and analyzed
Fig. 4. Kinetics of human B spermatogonia. (A,B) Distribution of mitotic B spermatogonia during the cycle of the seminiferous epithelium. (A) Representative
images of formalin-fixed testis sections stained for PHH3, KIT and acrosin to visualize the epithelial stage. Nuclei were stained with TO-PRO-3. Single arrow
indicates mitotic B spermatogonia at stage II. (B) Histogram showing the percentage of mitotic B spermatogonia (PHH3+/KIT+) per stage. A total of 260
PHH3+/KIT+ spermatogonia were counted in six samples. a***P<0.001 stage VI versus all other stages; b***P<0.001 stage IX versus stages I, IV and XII;
b**P<0.005 stage IX versus stages VII, X and XI; b*P<0.05 stage IX versus stages III and VIII; c***P<0.001 stage V versus stage XII; c**P=0.05 stage V versus
stage I; c*P<0.05 stage V versus stages IV, VII, X and XI; d*P<0.05 stage II versus stages I and XII; e*P<0.05 stage III versus stage XII. (C,D) Topographical
arrangement of clones of mitotic B spermatogonia. (C) Intact seminiferous tubules co-stained for PHH3 and KIT. Representative images of single B
spermatogonia, and pairs and groups of PHH3+ B spermatogonia. (D) Relative frequencies of single B spermatogonia, and pairs and groups of 3-32 mitotic B
spermatogonia in intact seminiferous tubules. A total of 260 PHH3+/KIT+ cells were scored in six samples. a*P<0.05 single versus all others except pair; b*P<0.05
pair versus all others except single. Scale bars: 20 µm.
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the expression of KI67 (Fig. 5A). To our surprise, only 55±10% of
the B spermatogonia were KI67+, suggesting that almost half of
human B spermatogonia are out of the cell cycle (Fig. 5B). Similar
results were obtained using a different KI67 antibody (data not
shown).
In rodents, all generations of differentiating spermatogonia are
continuously proliferating. To verify that KI67 is a good
spermatogonial proliferation marker, we studied KI67 expression in
mouse differentiating type spermatogonia. Examining long stretches
of seminiferous tubules, KIT+ spermatogonia negative for KI67 were
never observed, confirming that in the mouse all differentiating
spermatogonia are in active cell cycle (Fig. S5). This finding supports
the validity of using KI67 expression to study the proliferative activity
of human differentiating spermatogonia and our conclusion that a
considerable number of human B spermatogonia are not in the cell
cycle. The proliferation of human differentiating type spermatogonia
is apparently downregulated.
Furthermore, after each of the subsequent divisions, the number
of B spermatogonia should double and consequently also the
numbers of mitotic spermatogonia in the peaks. In contrast, the
second mitotic peak is not higher than the first peak, and the third
peak of mitotic B3 spermatogonia also does not seem to include
twice the number of mitotic B2 spermatogonia. To study whether
apoptosis could be the reason for the low numbers of mitotic B
spermatogonia, we performed TUNEL staining to detect apoptotic
cells. Indeed, apoptotic cells were detected on the basal lamina in
between MAGE-A4+ spermatogonia (Fig. 5C) and KIT+
spermatogonia (Fig. 5D), making apoptosis a probable cause of
the low peaks of mitotic B spermatogonia.
DISCUSSION
Viewing whole mounts of human seminiferous tubules, one sees
a surprisingly high density of spermatogonia with a highly
variable morphology, which makes it impossible to distinguish
spermatogonial subtypes. However, immunofluorescent staining for
GFRA1, UCH-L1, UTF1 and KIT allowed us to discern sequential
subpopulations of Ap-d spermatogonia. Furthermore, the regulation
of B spermatogonial proliferation appeared to be more elaborate
than in other mammalian species. The results led to the development
of a novel model for steady state kinetics of human spermatogonia.
It proved impossible to reliably subdivide undifferentiated
spermatogonia into Ap and Ad spermatogonia in tubule whole
mounts, too many cells have an ‘in between’ morphology,
suggesting a gradual transition from Ap to Ad sprematogonia. In
monkey spermatogenesis, cells that are also intermediate between
Ap and Ad spermatogonia have been described and these were
called A-transition (At) (Fouquet and Dadoune, 1986) or A-
unclassified (Aunc) (Simorangkir et al., 2005). Furthermore,
Ehmcke and Schlatt reported that, in primates, 25 to 50% of the A
spermatogonia cannot be unequivocally characterized as Ap or Ad
(Ehmcke and Schlatt, 2006). We decided not to subdivide Ap-d
spermatogonia on basis of their nuclear morphology but on the
expression of marker proteins.
Our results show that all human spermatogonial cell types express
MAGE-A4 and that 37% of the spermatogonia express KIT and are
therefore B spermatogonia. The remaining KIT− spermatogonia are
Ap-d spermatogonia that stain for UCHL1 with a small overlap of
cells staining weakly for UCLH1 and KIT that are likely in
transition between Ap-d and B (Fig. 6).
In line with our previous results, most Ap-d spermatogonia
express the GDNF receptor GFRA1 (Grisanti et al., 2009) (Fig. 6).
In this, human Ap-d spermatogonia resemble those of the rhesus
monkey in which all Ap-d spermatogonia express GFRA1
(Hermann et al., 2009). Only 6% of the GFRA1+ Ap-d
spermatogonia also express KI67, indicating that most of these
cells are not in cell cycle. The transcription factor UTF1 is also
expressed in a majority 56±4% of Ap-d and in very few B
spermatogonia. UTF1 has been associated with the capacity of
human embryonal carcinoma cells to differentiate in response to RA
(Lin et al., 2012). Interestingly, in rodents the differentiation of Aal
spermatogonia into differentiating type spermatogonia is induced
by RA. A few UTF1+ B spermatogonia weakly express UTF1 and
also weakly express KIT. In view of the suggested role of UTF1 in
RA action, it seems likely that the UTF1 weak B spermatogonia are
in the process of losing UTF1 and acquiring KIT expression during
the differentiation of Ap-d into B spermatogonia. Remarkably,
UTF1+ spermatogonia never co-stain for KI67, indicating that
UTF1 expressing Ap-d spermatogonia are quiescent. All
proliferative activity in the compartment of Ap-d spermatogonia
is therefore carried out by GFRA1+/UTF1− cells. Interestingly, the
expression level of GFRA1 in GFRA1+/UTF1− Ap-d is twofold
higher than in GFRA1+/UTF1+ Ap-d spermatogonia. This indicates
that the acquisition of UTF1 expression is an important step in the
development of Ap-d spermatogonia as they become both quiescent
and GFRA1Low.
Fig. 5. Regulation of human differentiating spermatogonia.
(A,B) Proliferation index of B spermatogonia. (A) Representative images of
intact seminiferous tubules co-stained for KI67 and KIT. (B) A total of 742
Ki67+/KIT+ and 633 Ki67−/KIT+ cells were scored in three samples.
(C,D) TUNEL assay on human seminiferous tubules. (C) Representative
images of intact seminiferous tubules co-stained for TUNEL, MAGE-A4
and TO-PRO-3. An enlargement of the boxed area is shown in C′.
(D) Representative images of intact seminiferous tubules co-stained for
TUNEL, KIT and TO-PRO-3. An enlargement of the boxed area is shown in D′.
Dashed lines indicate the outline of the seminiferous tubules. Scale bars:
10 µm in A′,A″; 20 µm in A,C′,D′; 50 µm in C,D.
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Based on our results, we suggest the following picture for the
human spermatogonial compartment. At the start of the human
spermatogenic lineage, there is a pool of GFRA1High/UTF1− Ap-d
comprising 32% of all Ap-d spermatogonia, which in the normal
epithelium slowly proliferate (Fig. 6). During each epithelial cycle,
some cells in the GFRA1+/UTF1− pool start to express UTF1 and
become part of a pool of quiescent UTF1+/GFRA1Low Ap-d,
comprising 56% of all Ap-d spermatogonia. At some point, GFRA1
expression is lost and the cells become part of a compartment of
GFRA1−/UTF1+ spermatogonia that may be competent to
differentiate into B1 spermatogonia, as evidenced by the
occurrence of cells that are weakly stained for both UTF1 and the
differentiation marker KIT (Fig. 6). In contrast to UTF1, UCH-L1 is
expressed in all Ap-d spermatogonia and, similarly to UTF1, UCH-
L1 expression is lost in B spermatogonia. Recently, a single cell
RNA-seq experiment was carried out on human spermatogonia
(Neuhaus et al., 2017). Heterogeneous expression profiles were
found but the results did not yet lead to a better insight into
spermatogonial behavior in humans. However, when the results can
be related to our initial scheme based on GFRA1, UTF1 and KIT
expression, the single-cell RNA-seq approach may well lead to a
further refinement of our proposed scheme. Our data obtained using
the marker PHH3, which labels the relatively rare mitotic Ap-d
spermatogonia in whole mounts of seminiferous tubules, show that
at least the majority of human Ap-d spermatogonia are single cells.
Some pairs of Ap-d spermatogonia were also found, but we do not
know whether these are true pairs or mitotic singles that happen to
be in the vicinity of one another. Comparable numbers of single
mitotic Ap-d spermatogonia and single mitotic B spermatogonia
were found. Single Ap-d spermatogonia apparently differentiate
into single B spermatogonia that subsequently enter the cell cycle
and comparable numbers of single Ap-d spermatogonia divide to
replenish the Ap-d spermatogonia lost to differentiation.
During the human epithelial cell cycle, there are three peaks of
mitotic activity of B spermatogonia indicating the presence of three
generations of B spermatogonia: B1, B2 and B3. As the B1
spermatogonia are single cells and probably some paired cells, this
means that the spermatocytes consist of clones of 8-16 cells
compared with about 1000 in mice (Russell et al., 1990). This
difference will be smaller in monkeys in which 4-5 spermatogonial
divisions have been found (Clermont and Antar, 1973; de Rooij and
Russell, 2000; Ehmcke et al., 2005; Fouquet and Dadoune, 1986).
We found three generations of B spermatogonia and not one
generation as previously described (Clermont, 1966b). In our
analysis we used the novel 12-stage classification and not the six-
stage classification of the human epithelial cycle used by Clermont
(Muciaccia et al., 2013). The shorter duration of each stage in the
novel classification allowed a more detailed analysis of mitotic
peaks.
Only few of the GFRA1High/UTF1− Ap-d spermatogonia stain for
KI67 and are therefore in active cell cycle. This begs the question of
howmuch proliferative activity is needed to replenish the Ap-d lost to
differentiation? Using our data, we can give a possible answer.
During the steady state, i.e. once every epithelial cycle, B1
spermatogonia should be formed by differentiation of Ap-d
spermatogonia. We showed that 37 out of every 100 spermatogonia
are B spermatogonia.When there is no apoptosis of B spermatogonia,
one-seventh of these cells (about five spermatogonia) should be B1
spermatogonia (1B1-2B2-4B3, so B1 spermatogonia compose one-
seventh of the total). We also found that only 15 out of every 100
GFRA1High/UTF1− Ap-d spermatogonia are in active cell cycle.
Therefore, during the steady state, about five out of 15 (one-third)
GFRA1High/UTF1− Ap-d spermatogonia, should divide once during
one epithelial cycle to replenish Ap-d spermatogonia lost to
differentiation. This suggests that, on average, the GFRA1High/
UTF1− Ap-d only divide once every three epithelial cycles, i.e. one
and a half months, and that these cells are out of the cell cycle for
prolonged periods of time. In comparison, in rodents and sheep, As,
Apr and Aal spermatogonia divide two or three times per epithelial
cycle (Lok and de Rooij, 1983; Lok et al., 1983; Tegelenbosch and de
Rooij, 1993). Furthermore, as indicated above, in this calculation five
UTF1+ Ap-d become B spermatogonia (i.e. 7% of UTF1+ Ap-d
spermatogonia) each epithelial cycle. This suggests that per epithelial
cycle, UTF1+ Ap-d only have a chance of about 7% to leave the pool
of quiescent Ap-d spermatogonia. Apparently, in each epithelial cycle
only a small proportion of the Ap-d can make the step to
differentiating type spermatogonia; therefore, on average, the
UTF1+ cells may stay quiescent for about 7-8 months.
It is conceivable that the long periods of time during which both
GFRA1High/UTF1− and GFRA1Low/UTF1+ Ap-d spermatogonia
are not in cell cycle brings along a gradual transition from the Ap to
the Ad morphology. When this is indeed the case for both these cell
types, the distinction between Ap and Ad spermatogonia clearly
does not relate to different cell types, and the latter would explain
why over time little progress has been made in understanding
primate spermatogonial behavior. Nuclear rarefaction zones, as seen
in typical Ad spermatogonia, have also been described in
undifferentiated spermatogonia in mice and the Chinese hamster,
and were found to be to restricted to cells in G0/G1 phase (de Rooij,
1973; Lok et al., 1982). Nothing can be said as yet about whether
or not the acquisition of Ad morphology influences the likelihood
of GFRA1High/UTF1− cells entering the cell cycle or the
responsiveness of the GFRA1Low/UTF1+ cells to a differentiation
stimulus. In rodents, the chains of A-aligned spermatogonia become
Fig. 6. Proposed scheme for human spermatogonial
multiplication and stem cell renewal, based on marker
protein expression and mitotic activity of the cells. The
SSCs reside in the GFRA1High/UTF1− Ap-d spermatogonia
and differentiating cells are recruited from GFRA1Low/UTF1+
Ap-d spermatogonia. Note the very low proliferative activity of
the Ap-d.
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quiescent at about stage II, at which point they become capable of
responding to induction of differentiation by retinoic acid (Endo
et al., 2015). Therefore, quiescence of the cells may be related to
competence of the cells towards induction of differentiation, and
UTF1 may be involved in inducing quiescence of these cells.
Although, in mouse, all differentiating type spermatogonia
express KI67, only 55% of human B spermatogonia do so. This
indicates that, at any given moment, almost half of human B
spermatogonia are not in active cell cycle. This may occur in two
ways: (1) B spermatogonia have a low random chance to enter the
cell cycle; or (2) they are inhibited to proliferate during particular
time periods of the epithelial cycle. The first possibility does not
seem attractive as it does not explain the occurrence of only three
mitotic peaks, in fact one would not even expect the presence of
peaks. The second option offers the possibility for the epithelium to
restrict the number of B spermatogonial divisions by inducing
quiescence of these cells during specific epithelial stages. Such a
regulatory pathway governing the number of differentiating
spermatogonial generations will have to be confirmed in further
studies. In rodents, differentiating spermatogonia are always in
active cell cycle. Apparently, in humans and possibly in other
primates, where generally about four or five generations of B
spermatogonia are described, there is a mechanism to control the
number of generations of differentiating type spermatogonia.
In addition, there may be density-related apoptosis of B
spermatogonia that causes a reduction of B spermatogonial
mitoses during the second and third mitotic peaks. Indeed, as
assessed by TUNEL staining, spermatogonial apoptosis does take
place. Apoptosis of differentiating type spermatogonia is observed
in all non-primate mammals and serves to regulate cell density. In
areas with many differentiating spermatogonia, many of these cells
will enter apoptosis; in areas with only few of these cells, few or
none will do so. This ensures an even distribution of preleptotene
spermatocytes over the tubule basal lamina (de Rooij and Janssen,
1987; de Rooij and Lok, 1987).
In humans and in some monkeys (Wistuba et al., 2003), areas that
are in the same epithelial stage are only small, leading to the
presence of multiple stages in the cross-section of one tubule. Our
data provide several reasons for this phenomenon. In humans, only
single spermatogonia and perhaps a few pairs of Ap-d
spermatogonia differentiate, instead of the chains of four to 16 Aal
spermatogonia in rodents. Furthermore, in humans there are fewer
generations of differentiating spermatogonia to follow than in
rodents, i.e. three instead of six, making a further eightfold
difference. Both reasons will lead to much smaller tubule areas
being in the same epithelial stage in humans than in rodents.
Thus far, both Ap and Ad spermatogonia have been considered to
be stem cells. Our results suggest that the SSCs will reside in the
population of the Ap-d spermatogonia that are GFRA1High/UTF1−.
However, one has to bewary of assigning a stem cell role to all these
cells, because in the mouse it has recently been shown that only
some of the single As spermatogonia are true stem cells, while the
rest of the single spermatogonia likely have a limited self-renewal
capacity (Aloisio et al., 2014; Chan et al., 2014; Helsel et al., 2017;
Komai et al., 2014; Oatley et al., 2011). Interestingly, mouse true
SSCs have recently been found to be GFRA1High (Helsel et al.,
2017), suggesting that in humans the 32% of Ap-d spermatogonia
that are GFRA1High/UTF1− are also, or at least include, SSCs. This
will need further studies.
In conclusion, GFRA1 and UTF1 are marker proteins that enable
one to subdivide the human spermatogonial compartment in a more
meaningful way than by using nuclear morphology. We suggest that
the development of Ap-d spermatogonia can be subdivided into
three steps: the earliest Ap-d spermatogonia that are GFRA1High and
include SSCs; the Ap-d spermatogonia that start to express UTF1,
followed by a reduction in GFRA1 expression and quiescence; and
finally the spermatogonia in which GFRA1 expression stops and the
cells become competent to differentiate into B spermatogonia
(Fig. 6). The study of additional markers may well add further
details to this process of Ap-d development and SSC renewal.
Furthermore, our results will be particularly helpful in the
interpretation of single RNA-seq data. In addition, it will facilitate
the understanding of cases of male infertility due to spermatogonial
failure and help the development of treatment strategies. In this
respect, when UTF1+ Ap-d are analogous to Aal spermatogonia, it is
interesting that the latter cells can already be induced to differentiate
in stages II to VI by injection of retinoic acid (Endo et al., 2015).
MATERIALS AND METHODS
Human testis sample collection
Testicular biopsies were used from heart-beating organ donors (n=15
samples from 19 to 75 years of age) at the hospital Policlinico Umberto I
(Rome, Italy). For each donor, the free and informed consent of the family
concerned, was obtained. The Ethical Committee of the hospital approved
the use of human material according to national guidelines for organ
donation as issued by the Italian Ministry of Public Health. Biopsies were
collected as previously described (Muciaccia et al., 2013). From each donor,
representative samples from different parts of the testis were collected. After
collection, the biopsies were transported in ice-cold phosphate buffered
saline (PBS) (Sigma-Aldrich) to the laboratory and processed within 1 h.
Biopsies were routinely fixed in Bouin’s fixative and embedded in paraffin
wax but in some instances samples were fixed in 10% buffered formalin
(Sigma-Aldrich) or 4% paraformaldehyde (PFA) (Electron Microscopy
Sciences). Some biopsies were left unfixed and used for short-term culture.
In order to check the integrity of the tissue and the preservation of
spermatogenesis, Bouin-fixed samples were paraffin wax-embedded,
sections stained with Mayer’s Hematoxylin and Eosin (Sigma-Aldrich),
and analyzed. All the samples included in this study showed well-preserved
testicular tissue and a normal spermatogenesis without any sign of fibrosis
or inflammation.
EdU incorporation and detection
Unfixed testicular fragments obtained from biopsies were cultured in
αMEMmedium containing 4 mM glutamine, 1% non essential amino acids,
2% penicillin/streptomycin, 0.08% gentamicin, 15 mM HEPES (pH 7.7)
and 10 µM EdU (5-ethynyl-2′-deoxyuridine) at 34°C in 5% CO2 for 2 h and
30 min (all reagents were from Thermo Fisher Scientific). After incubation,
fragments were gently dissociated to obtain isolated seminiferous tubules
and fixed in 4% paraformaldehyde at 4°C for 4 h. EdU detection was
performed by following the protocol of the Click-iT EdU Imaging Kits
(Thermo Fisher Scientific). Following EdU detection, tubules were used to
detect various antigens using whole-mount immunofluorescence.
Immunofluorescence
Sections (5 μm) of formalin-fixed samples were processed in a microwave
oven for antigen retrieval in citrate buffer (pH 6.0; DAKO). To reduce
nonspecific background signal, sections were incubated with 1 M glycine
(Sigma-Aldrich) and subsequently with 1% BSA (Sigma-Aldrich) and 5%
normal donkey serum (Jackson Laboratories Immuno Research).
Subsequently, sections were incubated overnight at 4°C with appropriate
primary antibodies. The primary antibodies used are listed in Table S1. After
the washes, the sections were incubated with species-specific secondary
antibodies for 2 h at room temperature. All secondary ALEXA488- and
Cy3-conjugated antibodies were from Jackson Immuno Research. At the
end, the nuclei were counterstained with TO-PRO-3 Iodide (642/661)
(T3605, Thermo Fisher Scientific) and the slides closed with Vectashield
mounting medium (Vector Laboratories). Pictures were acquired using a
Leica TCS SP2 confocal microscope with a 40× oil immersion objective.
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For whole-mount immunofluorescence, seminiferous tubules were
disentangled from testicular biopsies and immediately fixed in 4% PFA at
4°C for 4 h. Fixed tubules were permeabilized with 0.5% Triton X100, treated
with 1 Mglycine for 1 h, andwith 0.1%TritonX-100, 1%BSA and 5%normal
donkey serum in PBS overnight at 4°C. The following day, tubules werewashed
in 1% BSA, 0.1% Triton X-100 in PBS (three times for 30 min) and incubated
overnight at 4°C with appropriate primary antibodies (Table S1).
The following day, tubules were washed as above and incubated with
species-specific secondary antibodies conjugated to Alexa 488-, Cy3- or
Cy5-conjugated fluorochromes for 2 h at room temperature. Primary and
secondary antibodies were diluted in 1% BSA and 0.1% Triton X-100 in
PBS. After the secondary antibody, tubules were washed as above and
nuclei were stained with TO-PRO-3. Tubules were mounted onto slides
using Vectashield mounting medium and observed using a Leica TCS SP2
confocal microscope with 40× oil immersion objective or an inverted
Olympus IX83 microscope with 60× water immersion objective.
Whole-mount immunofluorescence analysis of adult mouse seminiferous
tubules was performed as previously described (Corallini et al., 2006). Fixed
seminiferous tubules were incubated with primary antibodies (Table S1) at
4°C for 16 h under constant shaking. After washing, the tubules were
incubated with the species-specific conjugated secondary antibodies for 2 h
at room temperature. Nuclei were stained with TO-PRO-3.
For quantification of GFRA1 expression levels, intact seminiferous
tubules from three different testis samples were co-stained for GFRA1 and
UTF1. Z-stacks were acquired using a Leica TCS SP2 confocal microscope
at 1 µm increments between z-slices using a 40× oil immersion objective.
All images were taken under the same conditions. The mean fluorescence
intensity was quantified using LAS AF Software. For each donor, 80 cells
were selected and analyzed from several seminiferous tubules.
TUNEL assay
The TUNEL (TdT-mediated X-dUTP nick end labeling) assay on human
intact seminiferous tubules was performed as previously described (Hamer
et al., 2003) using the In Situ Cell Death Detection Kit, Fluorescein (Roche
Diagnostic) with minor modifications. The PFA-fixed tubules were
permeabilized with 1% Triton X-100 (Sigma-Aldrich) for 1 h at room
temperature. After two washes in PBS some tubules were treated with
RNase-Free DNase Set (Qiagen) for 20 min at room temperature as a
positive control. Tubules were then briefly washed in PBS and incubated in
TUNEL mix (enzyme plus label) at 37°C for 2 h. As negative control, some
tubules were incubated only with the TUNEL label (without enzyme) at 37°C
for 2 h. Finally, tubules were washed three times with PBS and were used for
detection of different antigens using whole-mount immunofluorescence.
Imaging and spermatogonial quantification
In order to quantify the relative proportion of Ap-d subsets and the
proliferation index of Ap-d and B spermatogonia, intact seminiferous
tubules from at least three different testis samples were co-stained for
relevant antibodies. Owing to the convoluted nature of human seminiferous
tubules, in order to image the entire spermatogonial layer, z-stacks were
acquired using Leica TCS SP2 confocal microscope with a 40×oil
immersion objective or an inverted Olympus IX83 microscope with 60×
water immersion objective. For each testis sample, ten fields
(187.5×187.5 µm) were randomly selected from at least three different
seminiferous tubules. For each field, confocal z-stacks were acquired (at
1 µm increments between z-slices).
To estimate the size and the frequency of PHH3+/KIT+ groups, five
different samples were used. In each sample, stained tubules were
individually analyzed from the beginning to the end in order to detect
PHH3+/KIT+ cells. Z-stacks (at 1 µm increments between z-slices) were then
acquired for each field containing labeled cells.
In order to estimate the frequency of mitotic Ap-d and B spermatogonia,
testis sections from six samples were co-stained for relevant antibodies and
analyzed using Leica TCS SP2 confocal microscope with a 40× oil
immersion objective. PHH3+ spermatogonia were rare and therefore several
sections from each sample had to be analyzed to reach an adequate number
of observations. All quantifications were performed on stored
microphotographs using the LAS AF Software or Fiji/ImageJ Software.
Statistical analysis
All quantitative data are shown as the mean±s.e.m. To define the
significance of the differences between two groups, data were analyzed
using a t-test. To compare many groups, data were analyzed using one-way
analysis of variance (ANOVA) followed by a post hoc Fisher LSD Method.
The significance level was fixed at P=0.05.
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